Popular Asthma and Allergy Medicine Not Linked to Depression or Suicide
According to studies and the FDA the popular asthma and allergy medication Singulair is not linked to depression or suicide, this comes after its parent company Merck had changed the warning label to include tremors, depression, suicide and anxiousness.
The American Lung Association will publish the fidings from this study that was conducted about the safety of the drug in the Journal of Allergy and Clincal Immunology according to a statement.
The study that was conducted by researchers Janet Holbrook and Raida Harik-Khan, was to analyze data from clinical trials that were conducted using Singulair and a placebo for changes in the emotional state of the participants.
The analyzing of the Singuliar trials came after the U.S. Food and Drug Administration announced in March that the drug could be linked to changes in mood or behavior and also to suicides.
According to Chief Medical Officer Norman Edelman of the American Lung Association in many cases doing studies on a medication that has been approved and is on the market is usually difficult. He stated that with Singulair the data that had been compiled during studies was invaluable. This is because there was data from a large group of participants.
The debate swirling around many of these medications is probably the reason that so many of the nutritional supplements out there such as Himalayan goji juice are becoming so popular. It is easy to understand why. You can spend some money now on a nutritional supplement such as goji juice or super greens or what have you and you do not have to spend a fortune later and deal with all of the hazardous side effects and other hassles assocaiated with certain medications that are out there.
